Abstract
Dermatofibrosarcoma protuberans (DP), an infiltrative skin tumour of intermediate malignancy, presents specific cytogenetic features such as reciprocal translocations t(17;22)(q22;q13.1) or supernumerary ring chromosomes derived from t(17;22). We have previously shown that both rings and translocated chromosomes derived from t(17;22) presented the same molecular rearrangement with fusion of the COL1A1 gene on chromosome 17 to the PDGFB gene on chromosome 22. To study the structure and function of the COL1A1–PDGFB chimeric protein, we used a tumour-derived chimeric COL1A1–PDGFB cDNA to perform stable and transient transfections in the Chinese hamster lung fibroblastic cell line PS200 and the human epithelial cell line HEK293. We demonstrated that the stably transfected clones that expressed the COL1A1–PDGFB chimeric protein became growth factors independent and tumorigenic in nude mice. In addition, COL1A1–PDGFB transfected cell supernatants significantly stimulated fibroblastic cell growth, through the activation of the PDGFB receptor pathway. By using anti-PDGFB and specific anti-COL1A1–PDGFB antibodies, we showed that, similar to PDGFB, the COL1A1–PDGFB chimeric proteins are processed in transfected cells into mature PDGFB dimers. These results strongly suggest that the COL1A1–PDGFB chimeric gene expression associated with DP, induces tumours formation through production of mature PDGFB, in an autocrine or paracrine way. Strikingly, mutagenesis experiments indicated that uncleaved COL1A1–PDGFB forms are mitogenic and therefore could contribute, as well as mature PDGFB, to the establishment of a transformed phenotype.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alves F, Vogel W, Mossie K, Millauer B, Hofler H, Ullrich A . 1995 Oncogene 10: 609–618
Dalgleish R . 1997 Nucleic Acids Res. 25: 181–187
Dirks RP, Jansen HJ, Onnekink C, De Jonge RJ, Bloemers HP . 1993 Eur. J. Biochem. 216: 487–495
Doolittle RF, Hunkapiller MW, Hood LE, Devare SG, Robbins KC, Aaronson SA, Antoniades HN . 1983 Science 221: 275–277
Enzinger FM, Weiss SW . 1995 Soft tissue tumors. The CV Mosby Company, St Louis
Fish FS . 1996 Dermatol. Surg. 22: 268–273
Fleming TP, Matsui T, Molloy CJ, Robbins KC, Aaronson SA . 1989 Proc. Natl. Acad. Sci. USA 86: 8063–8067
Greco A, Fusetti L, Villa R, Sozzi G, Minoletti F, Mauri P, Pierotti MA . 1998 Oncogene 17: 1313–1319
Heldin CH, Ostman A, Ronnstrand L . 1998 Biochim. Biophys. Acta 1378: F79–F113
Kikuchi K, Soma Y, Fujimoto M, Kadono T, Sato S, Abe M, Ohhara K, Takehara K . 1993 Biochem. Biophys. Res. Commun. 196: 409–415
Li X, Ponten A, Aase K, Karlsson L, Abramsson A, Uutela M, Backstrom G, Hellstrom M, Bostrom H, Li H, Soriano P, Betsholtz C, Heldin CH, Alitalo K, Ostman A, Eriksson U . 2000 Nat. Cell Biol. 2: 302–309
Meloche S, Pages G, Pouyssegur J . 1992a Mol. Biol. Cell. 3: 63–71
Meloche S, Seuwen K, Pages G, Pouyssegur J . 1992b Mol. Endocrinol. 6: 845–854
Mentzel T, Beham A, Katenkamp D, Dei Tos AP, Fletcher CD . 1998 Am. J. Surg. Pathol. 22: 576–587
Navarro M, Simon MP, Migeon C, Turc-Carel C, Pedeutour F . 1998 Genes Chromosomes Cancer 23: 263–266
O'Brien KP, Seroussi E, Dal Cin P, Sciot R, Mandahl N, Fletcher JA, Turc-Carel C, Dumanski JP . 1998 Genes Chromosomes Cancer 23: 187–193
Ostman A, Thyberg J, Westermark B, Heldin CH . 1992 J. Cell. Biol. 118: 509–519
Pages G, Lenormand P, L'Allemain G, Chambard JC, Meloche S, Pouyssegur J . 1993 Proc. Natl. Acad. Sci. USA 90: 8319–8323
Pedeutour F, Simon MP, Minoletti F, Sozzi G, Pierotti MA, Hecht F, Turc-Carel C . 1995 Cancer Res. 55: 2400–2403
Pedeutour F, Simon MP, Minoletti F, Barcelo G, Terrier-Lacombe MJ, Combemale P, Sozzi G, Ayraud N, Turc-Carel C . 1996 Cytogenet. Cell. Genet. 72: 171–174
Perez-Rodriguez R, Chambard JC, Van Obberghen-Schilling E, Franchi A, Pouyssegur J . 1981 J. Cell. Physiol. 109: 387–396
Rao CD, Pech M, Robbins KC, Aaronson SA . 1988 Mol. Cell. Biol. 8: 284–292
Royce PM, Steinmann B . 1993 John Wiley and sons, Inc: New York
Sardet C, Franchi A, Pouyssegur J . 1989 Cell 56: 271–280
Shimizu A, O'Brien KP, Sjoblom T, Pietras K, Buchdunger E, Collins VP, Heldin CH, Dumanski JP, Ostman A . 1999 Cancer. Res. 59: 3719–3723
Shrivastava A, Radziejewski C, Campbell E, Kovac L, McGlynn M, Ryan TE, Davis S, Goldfarb MP, Glass DJ, Lemke G, Yancopoulos GD . 1997 Mol. Cell. 1: 25–34
Simon MP, Pedeutour F, Sirvent N, Grosgeorge J, Minoletti F, Coindre JM, Terrier-Lacombe MJ, Mandahl N, Craver RD, Blin N, Sozzi G, Turc-Carel C, O'Brien KP, Kedra D, Fransson I, Guilbaud C, Dumanski JP . 1997 Nat. Genet. 15: 95–98
Smits A, Funa K, Vassbotn FS, Beausang-Linder M, af Ekenstam F, Heldin CH, Westermark B, Nister M . 1992 Am. J. Pathol. 140: 639–648
Vogel W, Gish GD, Alves F, Pawson T . 1997 Mol. Cell. 1: 13–23
Wang J, Hisaoka M, Shimajiri S, Morimitsu Y, Hashimoto H . 1999 Diagn. Mol. Pathol. 8: 113–119
Waterfield MD, Scrace GT, Whittle N, Stroobant P, Johnsson A, Wasteson A, Westermark B, Heldin CH, Huang JS, Deuel TF . 1983 Nature 304: 35–39
Westermark B, Sorg C . 1993 Cytokines, Vol 5 Sorg C (ed) Karger S, Basel pp 1–167
Acknowledgements
We thank Marie-Josée Terrier-Lacombe and Jean-Michel Coindre for providing samples of tumours, and we are grateful to Florence Pedeutour, Soumeya Bekri and Christiane Brahimi-Horn for the critical review of the manuscript and to Roselyne Tournaire for helpful discussions and suggestions. This study was supported in part by CNRS, the Association pour la Recherche sur le Cancer and the Ligue Nationale contre le Cancer.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Simon, MP., Navarro, M., Roux, D. et al. Structural and functional analysis of a chimeric protein COL1A1-PDGFB generated by the translocation t(17;22)(q22;q13.1) in Dermatofibrosarcoma Protuberans (DP). Oncogene 20, 2965–2975 (2001). https://doi.org/10.1038/sj.onc.1204426
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204426
Keywords
This article is cited by
-
Impact of human adipose tissue-derived stem cells on dermatofibrosarcoma protuberans cells in an indirect co-culture: an in vitro study
Stem Cell Research & Therapy (2021)
-
Diagnosis of fusion genes using targeted RNA sequencing
Nature Communications (2019)
-
Unusual presentation of dermatofibrosarcoma protuberans in a male patient’s breast: a case report and review of the literature
World Journal of Surgical Oncology (2015)
-
The off-label use of targeted therapies in sarcomas: the OUTC’S program
BMC Cancer (2014)
-
Pediatric sarcomas: translating molecular pathogenesis of disease to novel therapeutic possibilities
Pediatric Research (2012)